Bone formation in custom-made cranioplasty: evidence of early and sustained bone development in bioceramic calcium phosphate implants. Patient series.

CaP = calcium phosphate IF = implant failure SSI = surgical site infection TBI = traumatic brain injury bone formation calcium phosphate cranioplasty implant failure

Journal

Journal of neurosurgery. Case lessons
ISSN: 2694-1902
Titre abrégé: J Neurosurg Case Lessons
Pays: United States
ID NLM: 9918227275606676

Informations de publication

Date de publication:
26 Apr 2021
Historique:
received: 29 11 2020
accepted: 11 12 2020
entrez: 20 7 2022
pubmed: 26 4 2021
medline: 26 4 2021
Statut: epublish

Résumé

Implant failure (IF) rates in cranioplasty remain high despite efforts to reduce the incidence. New biomaterials may be part of the solution for this problem. Formation of autologous bone in implants may reduce rates of infection and subsequent failure. Four patients with calcium phosphate implants supported by titanium mesh and undergoing surgery for reasons unrelated to IF were included in this series. Samples from the implants were microscopically examined. Pathological studies proved the formation of autologous bone in the calcium phosphate implants. Bone and blood vessel formation in the implants and diminished foreign body reaction to autologous bone may reduce the rates of IF.

Sections du résumé

BACKGROUND BACKGROUND
Implant failure (IF) rates in cranioplasty remain high despite efforts to reduce the incidence. New biomaterials may be part of the solution for this problem. Formation of autologous bone in implants may reduce rates of infection and subsequent failure.
OBSERVATIONS METHODS
Four patients with calcium phosphate implants supported by titanium mesh and undergoing surgery for reasons unrelated to IF were included in this series. Samples from the implants were microscopically examined. Pathological studies proved the formation of autologous bone in the calcium phosphate implants.
LESSONS CONCLUSIONS
Bone and blood vessel formation in the implants and diminished foreign body reaction to autologous bone may reduce the rates of IF.

Identifiants

pubmed: 35855216
doi: 10.3171/CASE20133
pii: CASE20133
pmc: PMC9245784
doi:

Types de publication

Case Reports

Langues

eng

Pagination

CASE20133

Informations de copyright

© 2021 The authors.

Déclaration de conflit d'intérêts

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Références

Int J Oral Maxillofac Implants. 2020 Jan/Feb;35(1):70-78
pubmed: 31923291
J Mech Behav Biomed Mater. 2015 Mar;55:191-200
pubmed: 26594779
J Orthop Trauma. 2003 Mar;17(3):212-6
pubmed: 12621263
World Neurosurg. 2015 Feb;83(2):176-80
pubmed: 24909393
J Plast Reconstr Aesthet Surg. 2010 Oct;63(10):1615-23
pubmed: 19577527
J Neurosurg. 2018 Sep 14;131(3):735-739
pubmed: 30215553
J Clin Neurosci. 2017 Jul;41:30-35
pubmed: 28377284
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26660-26671
pubmed: 33046631
Int J Stroke. 2011 Feb;6(1):79-86
pubmed: 21205246
Biomater Res. 2019 Jan 14;23:4
pubmed: 30675377
Br J Neurosurg. 2016 Oct;30(5):523-8
pubmed: 27215939
Regen Biomater. 2018 Feb;5(1):43-59
pubmed: 29423267
N Engl J Med. 2016 Sep 22;375(12):1119-30
pubmed: 27602507
Ann Plast Surg. 2015 May;74(5):603-8
pubmed: 25875725
J Neurosurg. 2014 Jan;120(1):273-7
pubmed: 23909245
Neurosurg Focus. 2014 Apr;36(4):E20
pubmed: 24684333
Neurosurg Focus. 2014 Apr;36(4):E19
pubmed: 24684331
Lancet Neurol. 2009 Apr;8(4):326-33
pubmed: 19269254
Acta Neurochir (Wien). 2019 Jun;161(6):1255-1259
pubmed: 31041594
Plast Reconstr Surg Glob Open. 2015 Aug 25;3(8):e491
pubmed: 26495204
Materials (Basel). 2017 Mar 24;10(4):
pubmed: 28772697
Stem Cells Int. 2012;2012:236231
pubmed: 25098363
Eur Cell Mater. 2008 May 02;15:100-14
pubmed: 18454418
Mil Med. 2008 Jul;173(7):697-9
pubmed: 18700607

Auteurs

Jimmy Sundblom (J)

Departments of Neuroscience Neurosurgery and.

Fabjola Xheka (F)

Clinical Pathology, Uppsala University Hospital, Uppsala, Sweden; and.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Olivera Casar-Borota (O)

Clinical Pathology, Uppsala University Hospital, Uppsala, Sweden; and.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Mats Ryttlefors (M)

Departments of Neuroscience Neurosurgery and.

Classifications MeSH